Latest / Pharmacy Podcast Network / A Collaborative Approach to Medical Information | phactmi: Empowering Healthcare Decisions
Transcript
- 0:06Speaker 1: As you are listening to the Pharmacy podcast Network.
- 0:14Speaker 2: Hi, this is John Stills Miller, CEO of Fact Demi
- 0:18Speaker 2: and this is the Fact of My podcast series. The
- 0:23Speaker 2: achievements of any organization are the results of the combined
- 0:26Speaker 2: efforts of every individual. Fact Demi was established in twenty
- 0:31Speaker 2: fourteen to increase awareness and enhance access to relevant and
- 0:35Speaker 2: evidence based drug information. This is the same mission that
- 0:39Speaker 2: drives Fact Demi. Today. Happy ten year anniversary to Fact Demi.
- 0:44Speaker 3: Our host Evelyn DeSantis talks with medical information experts about
- 0:48Speaker 3: the challenges of keeping up to date with drug info,
- 0:51Speaker 3: consequences on misinformation and healthcare and medical information as a resource,
- 0:56Speaker 3: and the people behind this data from the pharmaceutical industry insiders.
- 1:00Speaker 4: Welcome back.
- 1:01Speaker 5: This is the Fact of My podcast series. They have
- 1:04Speaker 5: returned to deliver medical information for healthcare providers. Lots of
- 1:11Speaker 5: this is led by pharmacists, which is exciting to me.
- 1:14Speaker 5: This series is called Empowering Healthcare Decisions and we are
- 1:18Speaker 5: on episode four. Don't worry if you don't have if
- 1:23Speaker 5: you haven't listened to the other three episodes, we will
- 1:25Speaker 5: have them in the show notes and coming back our
- 1:28Speaker 5: host Evelyn. It's so good to have you back as
- 1:31Speaker 5: part of the fact of my team and really structuring
- 1:34Speaker 5: this and having some very special guests with us today
- 1:38Speaker 5: talking about a collaborative approach to medical information. Welcome back, Thank.
- 1:43Speaker 1: You Chad, and thank you so much for helping us
- 1:46Speaker 1: out with this podcast series. I can't believe for Orion
- 1:49Speaker 1: episode four, but this has been a great experience and
- 1:54Speaker 1: hopefully we've been able to provide some really good information
- 1:57Speaker 1: to our pharmacists out there. I'm excited about this one
- 2:02Speaker 1: as we kind of can take a look at where
- 2:05Speaker 1: we're going in kind of the future as well. So
- 2:08Speaker 1: I really would like to thank today's panelists who are
- 2:12Speaker 1: going to be sharing their stories with us. With us today,
- 2:16Speaker 1: we have Stacy Funk from Giliad. In addition, I'll give
- 2:20Speaker 1: her a shout out to her. She is the president
- 2:22Speaker 1: of current president of the board of fact am I,
- 2:26Speaker 1: Lena Jindia from Jay and Jay, one of our past
- 2:29Speaker 1: presidents actually a fact am I, and Vach Demercian from Pfizer.
- 2:35Speaker 1: So Stacy, Lena Vace, I just want to thank you
- 2:37Speaker 1: guys for being here today and just kind of turn
- 2:41Speaker 1: over to you guys to say, can you just briefly
- 2:43Speaker 1: share a little bit about yourself and your current position.
- 2:47Speaker 1: Stacy will let you kick it off.
- 2:50Speaker 6: Thank you, Evelyn, definitely thank you for the invitation to
- 2:53Speaker 6: join this podcast. As Evelyn mentioned, I'm Stacey Bung and
- 2:57Speaker 6: I am currently the President of the Board of Directors
- 2:59Speaker 6: of FACT. I actually was a director at large prior
- 3:04Speaker 6: to becoming the board of director's president, actually was the
- 3:08Speaker 6: vice president previously, so it's been a good journey with
- 3:11Speaker 6: Fact DEMI. I currently head up the Global Medical Information
- 3:16Speaker 6: Team at Gilead Sciences. And to share a little bit
- 3:19Speaker 6: about myself, I've actually been in pharma for quite a
- 3:22Speaker 6: bit of twenty plus years, specifically in medical information. I
- 3:27Speaker 6: am also a pharmacist by training, so that's something I
- 3:31Speaker 6: really am proud of that I was able to start
- 3:33Speaker 6: off my pharmacy career as a retail and hospital pharmacist
- 3:37Speaker 6: and then parlay that into a medical information specialist at
- 3:42Speaker 6: various companies throughout the year. But it's been a journey
- 3:45Speaker 6: and I'm so glad that I've been able to join
- 3:47Speaker 6: the FACT DEMI team and see and meet so many
- 3:51Speaker 6: medical information specialists who are pharmacists also. So I like
- 3:55Speaker 6: to also pass it over to Lena who I've known
- 3:58Speaker 6: for many years because of the journey that we've had
- 4:01Speaker 6: as pharmacists as well as confirmation.
- 4:04Speaker 4: Awesome, thank you Stacy, and yes, delighted to be here
- 4:07Speaker 4: today with Evelyn and the panelist. Similar to Stacy, I'm
- 4:13Speaker 4: a pharmacist by training, so again, Lena Gindia. I lead
- 4:18Speaker 4: the Medical Information Department within Johnson and Johnson, which includes
- 4:23Speaker 4: the Medical Information Scientific Engagement Team, Established Products Group, Global
- 4:29Speaker 4: Scientific Content and Content Innovation. I've been with Janja for
- 4:34Speaker 4: twenty four years in various roles within medical affairs and
- 4:38Speaker 4: medical information, and I too have been an active member
- 4:43Speaker 4: of fact am I in fact since the inception in
- 4:46Speaker 4: twenty fourteen, so we are celebrating our tenure anniversary this year.
- 4:52Speaker 4: I was a board member since twenty sixteen and then,
- 4:56Speaker 4: as Evelyn mentioned, a president of the board in twenty
- 5:01Speaker 4: twenty one and twenty two. So thank you for the invite, Evelyn,
- 5:06Speaker 4: and delighted to be here. I'll turn it over to
- 5:09Speaker 4: BArch for introduction.
- 5:12Speaker 7: Thanks Alena, and thank you Evelyn for having me on
- 5:15Speaker 7: the podcast today. I'm very excited to be participating in
- 5:19Speaker 7: my first fact am I project or podcast. Rather, so again,
- 5:24Speaker 7: my name is Bachi Demergin. I'm currently the Director of
- 5:27Speaker 7: Operational Excellence Advisor supporting the Rare Disease Medical Affairs team.
- 5:32Speaker 7: Before joining Pfizer, I spent several years in the field
- 5:36Speaker 7: as an MSL or medical advisor. I'm at a few
- 5:39Speaker 7: different biotechs, always supporting rare disease. But before I was
- 5:44Speaker 7: in MSL, I actually started my industry career in global
- 5:47Speaker 7: medical information working at Alexion. So very excited to have
- 5:52Speaker 7: that medical information background which has been so helpful to
- 5:56Speaker 7: my career, and I'm really looking for forward to you know,
- 6:02Speaker 7: like I said participating in this podcast, and very much
- 6:04Speaker 7: like Stacy Lena, I'm also a pharmacist by training, graduating
- 6:09Speaker 7: from mcphs in Boston, and I completed my postgraduate work
- 6:13Speaker 7: in New Jersey.
- 6:14Speaker 1: Wonderful guys, thank you so very much for that. As
- 6:20Speaker 1: Lena said, FACTAMI is celebrating its ten year anniversary this year,
- 6:26Speaker 1: and Stacy, I was wondering if you might be able
- 6:28Speaker 1: to provide us with some background in history about fact DEMI.
- 6:35Speaker 6: Sure. Fact Demi is the well, we would say, premier
- 6:39Speaker 6: organization showcasing the strategic value of medical information, content, services
- 6:45Speaker 6: and professionals. So it really serves as both an industry
- 6:49Speaker 6: center of excellence and a primary source of medical information
- 6:53Speaker 6: for our healthcare professionals, patients, and partners. It really is
- 6:58Speaker 6: enabling our pharmaceutical manufacturers to leverage all of the medical information, expertise, services,
- 7:08Speaker 6: everything that we do as a function as a profession.
- 7:12Speaker 6: So to start off, as Evelyn and Lena both mentioned,
- 7:15Speaker 6: fact in I began about ten years ago, initially with
- 7:19Speaker 6: nineteen medical information leaders coming together to address industry challenges.
- 7:24Speaker 6: This was really interesting because I was not part of
- 7:26Speaker 6: that beginning. My senior director at the time that led
- 7:31Speaker 6: the department was one of our was one of the
- 7:33Speaker 6: leaders that came together, and they all identified so many
- 7:38Speaker 6: challenges that all of the individual companies were having but
- 7:42Speaker 6: were similar. So they decided a year later to formally
- 7:46Speaker 6: established back to AMI as a what we would call
- 7:50Speaker 6: five oh one c six nonprofit organization, and today it
- 7:55Speaker 6: actually probably continues its mission with over thirty five member
- 7:58Speaker 6: organizations and we're all committed to improving patient lives through
- 8:03Speaker 6: the safe and effective use of medicine. So really, as
- 8:06Speaker 6: a consortium, we want to make sure that our healthcare
- 8:09Speaker 6: professionals and patients have the information they need, but we
- 8:13Speaker 6: as a profession can work together collaboratively to do that.
- 8:17Speaker 8: Thank you, So, Lena, I want to throw it over
- 8:20Speaker 8: to you, and you know if you've had the experience
- 8:23Speaker 8: with Factormie since its inception, so thank you for being
- 8:28Speaker 8: part of that group.
- 8:30Speaker 1: I think factim has been able to do some amazing
- 8:33Speaker 1: things because of the group that came together to kind.
- 8:36Speaker 9: Of start it.
- 8:37Speaker 1: But I want to dig in a little bit about
- 8:41Speaker 1: what do you see that collaborative process of medical information.
- 8:45Speaker 4: Being absolutely Evelyn So manical information truly plays a very
- 8:51Speaker 4: crucial role within the pharmaceutical industry as we gather all
- 8:57Speaker 4: these insights from our customers through the voice of customer
- 9:02Speaker 4: scientific interaction, which really highlights the unmet medical need that
- 9:09Speaker 4: feed into evidence generation medical strategy for a given product. So,
- 9:16Speaker 4: because of the role and where we sit in the organization,
- 9:20Speaker 4: we collaborate across different functional partners across medical affairs, commercial,
- 9:28Speaker 4: R and D global to ensure that we are serving
- 9:33Speaker 4: as the champions for the customers that we have scientific engagement,
- 9:39Speaker 4: be it AHCPS, patients or peers. So the role of
- 9:45Speaker 4: Medical Information Department in pharma is really to provide pair,
- 9:51Speaker 4: accurate and unbiased medical information to support the safe and
- 9:56Speaker 4: effective use of our product. Typically are staffed by pharmacists
- 10:01Speaker 4: and scientists who evaluate the scientific evidence of a given product,
- 10:06Speaker 4: and since the scynthifize that evidence into medical information responses,
- 10:12Speaker 4: so again we collaborate with our scientific customer facing teams MSLS,
- 10:20Speaker 4: our VNY field based team members, even our commercial sales
- 10:26Speaker 4: reps to ensure that there is collaboration on how we
- 10:31Speaker 4: are communicating the scientific evidence of our products supporting off
- 10:36Speaker 4: label uses.
- 10:37Speaker 2: UH.
- 10:37Speaker 4: And then of course the scientific training that goes behind it.
- 10:42Speaker 4: Since we are the scientific experts or the product and
- 10:45Speaker 4: disease state experts in that serving in that capacity.
- 10:50Speaker 6: Let me just add and so this is stacy. I
- 10:51Speaker 6: want to just add that factim I actually builds on
- 10:54Speaker 6: all of those things that each of the individual companies
- 10:58Speaker 6: are engaging collaborating with their cross functional partners. So what's
- 11:02Speaker 6: so unique about back DEMI is it brings all of
- 11:05Speaker 6: those expertise from each of our companies. We know that
- 11:10Speaker 6: medical information specialists across the industry within their organizations engage
- 11:15Speaker 6: with the research team, the regulatory affairs team, the drug
- 11:20Speaker 6: safety pharmacle vigilance professionals, the medical writers and data scientists,
- 11:25Speaker 6: and each of us have different experience that we bring
- 11:28Speaker 6: to fact DEMI, and by pulling these diverse skills as
- 11:33Speaker 6: well as expertise, factim I actually it allows FACTAMI to
- 11:37Speaker 6: create a robust knowledge base that can address the complex
- 11:41Speaker 6: inquiries and provide comprehensive, up to date information. We build
- 11:44Speaker 6: on each other's expertise. So I think this is something
- 11:47Speaker 6: that's very unique to FACTIMI, is that we learn from
- 11:50Speaker 6: each other. And this is in addition, I mean, this
- 11:53Speaker 6: is basically our collaborative, collaborative effect of a consortium. So
- 11:58Speaker 6: not only does an am I professional in their organization
- 12:02Speaker 6: have so many cross functional collaborations, but within fact and I,
- 12:06Speaker 6: we're also leveraging that experience so that we can build
- 12:10Speaker 6: stronger medical information professionals. So I'd like to just add
- 12:14Speaker 6: to that aspect of what fact am I is also
- 12:18Speaker 6: leveraging and building upon all of our member companies.
- 12:24Speaker 1: Stacy, thank you for that edition. I agree wholeheartedly. When
- 12:28Speaker 1: I've seen I still remember a meeting years ago and
- 12:33Speaker 1: there was a new.
- 12:34Speaker 10: Head of medical who had attended one of the fact
- 12:38Speaker 10: of MY meetings, and he came from a commercial side,
- 12:42Speaker 10: and he looked stunned and amazed that there were that
- 12:47Speaker 10: many medical information individuals from different companies sitting in a
- 12:52Speaker 10: room and willingly.
- 12:54Speaker 1: Talking about how their process or their know the general
- 13:02Speaker 1: process and sharing that general knowledge. So I always thought
- 13:06Speaker 1: that was amazing to see.
- 13:09Speaker 6: I would also add that as pharmacists, we're always seeking
- 13:12Speaker 6: to understand and asking good questions. So when you have
- 13:16Speaker 6: a large group of pharmacists together, they not only share,
- 13:19Speaker 6: but they ask good questions. And so fact to Mine
- 13:22Speaker 6: does is a platform so that we can speak to
- 13:24Speaker 6: each other. We're all speaking the same language, but we
- 13:28Speaker 6: want to learn from each other and then improve the
- 13:30Speaker 6: way that we do things back at our organizations. So
- 13:34Speaker 6: there's that was a great example, Evlend. There's probably so
- 13:36Speaker 6: many more examples that we can pull from as we
- 13:39Speaker 6: all gathered together when we have our quarterly meetings or
- 13:43Speaker 6: when we meet and just do ad hoc conversations.
- 13:47Speaker 4: So and just to add Stacey, an example that came
- 13:52Speaker 4: to life for me was during COVID Uh fact am
- 13:57Speaker 4: I you know, was because we had our source him
- 14:00Speaker 4: already in place, we quickly gathered the member companies who
- 14:06Speaker 4: were working on any type of product for COVID, and
- 14:10Speaker 4: we shared best practices. We were able to you know,
- 14:14Speaker 4: helping each other, giving the types of learnings that each
- 14:19Speaker 4: company had so that the next company who was working
- 14:23Speaker 4: on a product, could you know, that can serve them
- 14:26Speaker 4: for the sake of their customers. And honestly, that was
- 14:29Speaker 4: really highlighted in my company as what a strong win
- 14:33Speaker 4: through fact, am I that we were able to bring
- 14:38Speaker 4: you know, technically their competitors, what we within the parameters
- 14:42Speaker 4: of what we could share. We really helped each other
- 14:45Speaker 4: for the sake of the you know, patients that we
- 14:47Speaker 4: all serve. So that was a real life example that
- 14:51Speaker 4: came to play during COVID and I just wanted to
- 14:53Speaker 4: share that.
- 14:58Speaker 1: Thank you so much, Lena, I think that was an
- 15:01Speaker 1: amazing example as well. Latch, I want to bring you
- 15:04Speaker 1: in on this conversation.
- 15:06Speaker 9: You have had a number of different roles within pharma,
- 15:09Speaker 9: from Medinfo to MSL to your current role in operational excellence.
- 15:15Speaker 9: How have you seen Medical Information partner with other parts
- 15:20Speaker 9: of the company to provide even better information to healthcare professionals.
- 15:26Speaker 7: Thanks for the question, Evelyn. Most medical affairs teams that
- 15:31Speaker 7: I've been a part of have a forum where multiple
- 15:34Speaker 7: cross functional partners gather, you know, either on a monthly
- 15:38Speaker 7: or a quarterly basis, and really focus on global strategy.
- 15:42Speaker 7: And one of the ways that really helps the global
- 15:46Speaker 7: teams make informed decisions is relying on insights that are
- 15:49Speaker 7: received from various areas throughout the company. And there's obviously
- 15:54Speaker 7: a couple of ways we can do this. We can
- 15:57Speaker 7: look at the insights from the field teams, from an
- 16:00Speaker 7: advisory board, from congresses, but medical information plays a very
- 16:05Speaker 7: important role in these discussions because the global teams want
- 16:09Speaker 7: to know what types of questions are we receiving from
- 16:12Speaker 7: HCPs from around the world. Are we seeing any trends
- 16:16Speaker 7: in the questions or information being requested? Are there currently
- 16:20Speaker 7: any gaps that we need to address, And sometimes these
- 16:24Speaker 7: trends trigger a light bulb for us on the global
- 16:26Speaker 7: team to say, you know, maybe there's an unmeant need
- 16:29Speaker 7: here and we need a better way to respond to hdps,
- 16:34Speaker 7: and maybe we can partner with another group in the
- 16:38Speaker 7: company and do a subanalysis for a particular study to
- 16:42Speaker 7: find that information, or we could partner with Pharmacal Vigilance
- 16:46Speaker 7: to generate more safety data so that we can address
- 16:49Speaker 7: this question. It's all about really creating a more robust
- 16:54Speaker 7: response that could really impact clinical decisions, And like Lena
- 16:58Speaker 7: and Stacy said, it's true across functional collaboration to bring
- 17:03Speaker 7: all of these insights together and create these responses that
- 17:07Speaker 7: can really impact the patient at the end of the day.
- 17:15Speaker 1: That is so interesting. Now looking at your current position
- 17:20Speaker 1: and really all of the different things that you've had
- 17:23Speaker 1: throughout your industry career, all of the different positions, how
- 17:27Speaker 1: has medical Information really helped you in your industry career.
- 17:33Speaker 7: It's been so important, and it was especially evident when
- 17:38Speaker 7: I first actually became an MSL and transition to the field.
- 17:43Speaker 7: I had spent about two years supporting Global Medical Information
- 17:47Speaker 7: by that time, and I had such a good understanding
- 17:50Speaker 7: of our assets and the disease state that it made
- 17:53Speaker 7: my field training a lot easier. I was able to
- 17:56Speaker 7: get up to speed quicker than maybe some of their
- 18:00Speaker 7: potential candidates that came from outside the company. So it
- 18:04Speaker 7: really saved me a lot of time. And I knew
- 18:07Speaker 7: where all of the information was stored. I knew where
- 18:09Speaker 7: the standard response documents where, I knew when they were
- 18:13Speaker 7: last updated. I knew what information went into creating those answers,
- 18:18Speaker 7: and even more so at the time we were launching
- 18:21Speaker 7: a new medication, and I helped create the FAQ document
- 18:26Speaker 7: that was being utilized by the field team. So again,
- 18:30Speaker 7: when I started, I knew all the common questions already,
- 18:33Speaker 7: I knew the answers. I knew what information we had
- 18:36Speaker 7: on file and more importantly, what information we did not
- 18:39Speaker 7: have on file. And that's when you know, we had
- 18:42Speaker 7: to escalate those questions to you know, the internal medical
- 18:46Speaker 7: Information team. But like I said, I think starting in
- 18:50Speaker 7: medical information really helped me build a strong foundation and
- 18:54Speaker 7: it was incredibly helpful as I transitioned to the field.
- 19:04Speaker 1: That's great, and I think that you know, that background
- 19:09Speaker 1: that you have in grounding you, as you said, in
- 19:12Speaker 1: medical information probably has added not only in your time
- 19:16Speaker 1: as an MSL and in the field team, but even
- 19:19Speaker 1: now in operational excellence. And you know, knowing what you know.
- 19:25Speaker 5: And knowing.
- 19:27Speaker 1: How to trust your other partners probably plays quite a
- 19:32Speaker 1: bit of a role in what.
- 19:33Speaker 8: You do as well.
- 19:35Speaker 7: It certainly does. And you know, as I mentioned in
- 19:38Speaker 7: these monthly forums, we oftentimes receive reports from the med
- 19:42Speaker 7: Info team and I'm able to, I think, better digest
- 19:47Speaker 7: that information and be able to apply that to our
- 19:52Speaker 7: actual like to our conversations and be able to see
- 19:55Speaker 7: those trends and like the questions that we're receiving the
- 19:58Speaker 7: common documents that we're utilizing to answer those questions. So
- 20:02Speaker 7: it certainly helps translate that information to some of the
- 20:06Speaker 7: other medical teams.
- 20:09Speaker 9: That's great.
- 20:12Speaker 1: I want to shift our focus a little bit right
- 20:15Speaker 1: now and instead of just looking you know, kind of
- 20:18Speaker 1: where we are and to some degree, where we've been
- 20:21Speaker 1: with fact am I, Stacy Lena, I'd love to gain
- 20:25Speaker 1: your perspectives on what are some of the future opportunities
- 20:29Speaker 1: for medical information and then also what role do you
- 20:33Speaker 1: see fact am I playing for that future?
- 20:38Speaker 6: So I'll take that first. Thanks Evelyn for the question.
- 20:42Speaker 6: I think that's a really important question for us to
- 20:45Speaker 6: think about, and what are the future opportunities for medical
- 20:48Speaker 6: information and what is the row of fact am I.
- 20:51Speaker 6: So that's something as president that I'm really been molling
- 20:54Speaker 6: over and really looking at the board to brainstorm and
- 20:59Speaker 6: what we should be thinking about. One of the things
- 21:02Speaker 6: I believe that medical information teams and our professionals are
- 21:06Speaker 6: ideally suited for is that we meet the hip and
- 21:11Speaker 6: patient need information needs, and so there is an opportunity
- 21:14Speaker 6: to support not only hps like we currently do, but
- 21:18Speaker 6: more for patients, you know, and as pharmacists we naturally
- 21:23Speaker 6: levitate to helping patients. But what's really interesting about medical
- 21:27Speaker 6: information is that we are actually one of the only
- 21:30Speaker 6: groups in medical affairs that can speak directly to or
- 21:34Speaker 6: engage directly with patients because they are calling the Medical
- 21:37Speaker 6: Information Department, So we do have specific patient insights. We
- 21:41Speaker 6: have the opportunity to talk to patients, and I don't
- 21:44Speaker 6: think that that's relatively known within the enterprise that medical
- 21:49Speaker 6: information people call medical information, patients call medical information and
- 21:53Speaker 6: we engage with them. So in this kind of landscape
- 21:58Speaker 6: of there's so much misinformation and disinformation disseminated on social
- 22:02Speaker 6: media and all the available channels, the role of the
- 22:05Speaker 6: medical information professional I believe is really important to provide
- 22:10Speaker 6: patients with accurate information really so they can actually be
- 22:14Speaker 6: a part of the conversation with their HGPS and their
- 22:19Speaker 6: medical teams. But this misinformation and disinformation, it's really a
- 22:23Speaker 6: concern for our pharma, for the FDA, and there was
- 22:28Speaker 6: recently a guidance about misinformation and what farmer companies can
- 22:32Speaker 6: do about it. So medical information teams have the expertise
- 22:36Speaker 6: and experienced support patient information needs. But of course there's
- 22:40Speaker 6: always that regulatory concern about and the risk and compliance
- 22:47Speaker 6: that we need to think about. So I think there's
- 22:50Speaker 6: there's some questions still about how medical information teams as
- 22:55Speaker 6: well as other farmer organizations can support patients when it's
- 23:01Speaker 6: not within the label. So I believe factor I should
- 23:05Speaker 6: be playing a row on helping our member companies as
- 23:09Speaker 6: well as shaping what that dialogue or what that narrative
- 23:14Speaker 6: could be. And so one of the things factorm I
- 23:17Speaker 6: currently is doing is we're working to develop a patient
- 23:20Speaker 6: resource hub. So our website actually is hosting all of
- 23:24Speaker 6: the patient response documents that our member companies currently have,
- 23:27Speaker 6: but we're also wanting to develop a patient resource patient
- 23:32Speaker 6: response hub for our members to really learn from each
- 23:35Speaker 6: other and also develop tools and resources that can help
- 23:40Speaker 6: our members develop these patient response documents or types of materials.
- 23:45Speaker 6: So that's one example of how factorm I is supporting
- 23:48Speaker 6: our member companies around patient engagement strategies. And this is
- 23:52Speaker 6: really leading the way to bring information for clinical decision
- 23:56Speaker 6: support to patients. But also patients are going to be
- 23:59Speaker 6: talking to their AI GPS. So just one example of
- 24:03Speaker 6: things that I can think of right now, and really
- 24:06Speaker 6: I feel that the future is around how do we
- 24:08Speaker 6: support our patient engagement, how do we support our organization
- 24:11Speaker 6: supporting patient engagement. So that's where I see our immediate
- 24:16Speaker 6: need is probably in the next two to three years.
- 24:19Speaker 6: I mean, I think we're always trying to talk to patients,
- 24:21Speaker 6: but we now have an opportunity and there's more of
- 24:24Speaker 6: an immediate need because of this misinformation and disinformation out
- 24:29Speaker 6: in the in the ecosphere.
- 24:34Speaker 4: Thank you, Stacy. And just to add on to that, Evelyn,
- 24:38Speaker 4: So patient engagement and being a champion for patients was
- 24:41Speaker 4: top off my list, and Stacy covered that very well.
- 24:45Speaker 4: So I'm going to move on because fact am I
- 24:47Speaker 4: again is doing you a lot of work in that space.
- 24:51Speaker 4: The other area of focus that I see is when
- 24:53Speaker 4: we look at our customers at large and specifically h cps, right,
- 24:58Speaker 4: they are inundated and overwhelmed with information overload. You know,
- 25:04Speaker 4: our h cps have to know the details about our
- 25:08Speaker 4: not only our products for our companies, but across the portfolio.
- 25:11Speaker 4: So that's thousands and thousands of products. Our attention span
- 25:15Speaker 4: as humans is going down with this overload, right, and
- 25:20Speaker 4: we are expected to retain the key elements of our
- 25:24Speaker 4: scientific evidence. So metical information really has a crucial role
- 25:31Speaker 4: there in making sure that the content that we are providing,
- 25:35Speaker 4: the scientific responses, meet the needs of those busy practitioners.
- 25:40Speaker 4: They can retain that information and hence you know, providing
- 25:45Speaker 4: personalized responses using data visualization techniques, making it bite size,
- 25:51Speaker 4: almost Google like responses where they get their answer right
- 25:55Speaker 4: away and if they want to drill down further they
- 25:58Speaker 4: can do so at their ease. But providing that response
- 26:02Speaker 4: at the point of care is critical, and I know
- 26:05Speaker 4: each of our member companies are working towards that. In fact,
- 26:08Speaker 4: FACTIMI is through our Innovations Committee, has a lot of
- 26:13Speaker 4: different ideas that we are piloting. We are bringing vendors
- 26:19Speaker 4: that have unique capabilities, so that's really really valuable for
- 26:24Speaker 4: our members that are maybe starting up a med info
- 26:28Speaker 4: group versus being more advanced as some of the members are.
- 26:33Speaker 4: So I think that's a key area in making sure
- 26:35Speaker 4: that we are meeting the demands of our customers, both
- 26:38Speaker 4: in content as well as channels of engagement for point
- 26:43Speaker 4: of care delivery. The other place that Stacey touched upon
- 26:48Speaker 4: is this whole concept of misinformation inaccurate or incomplete information.
- 26:55Speaker 4: We know that we struggle with that for our products
- 26:58Speaker 4: when they are misrepresented either in social media or in
- 27:02Speaker 4: different databases or compendia. So again, through fact am I,
- 27:08Speaker 4: we want to take a more proactive lead in addressing
- 27:12Speaker 4: that gap of misinformation about our products. In fact, we
- 27:17Speaker 4: have a consortium that we started on a workstream that
- 27:21Speaker 4: will be looking into that. You know, in the past,
- 27:23Speaker 4: fact AMI has come together to have white papers or
- 27:28Speaker 4: different research being published showing those inaccuracies about our products.
- 27:33Speaker 4: We want to take that to the next level and
- 27:36Speaker 4: have a workstream that now talks about you know, what
- 27:41Speaker 4: we have uncovered across different companies as regards with regards
- 27:45Speaker 4: to misinformation about our products, and perhaps even building relationships
- 27:51Speaker 4: with some of those you know, key data providers to
- 27:56Speaker 4: say hey, you may not want to talk to one
- 27:59Speaker 4: single company, but perhaps you know through the power of
- 28:02Speaker 4: fact am I, we can have a bigger impact in
- 28:06Speaker 4: those areas. And then lastly, Evelin I would say, you know,
- 28:10Speaker 4: gen AI generative AI is everywhere, including medical information. I
- 28:15Speaker 4: think that's a really key area for us to keep
- 28:19Speaker 4: an eye on and leverage for sake of efficiencies across
- 28:23Speaker 4: there's a lot of use cases in medical information. You know,
- 28:26Speaker 4: we are asked in medinfo to take on more and
- 28:30Speaker 4: more work with less resources as we get new product launches,
- 28:34Speaker 4: which is, hey, a great issue to have, but we
- 28:38Speaker 4: want to make sure that we are also being smart
- 28:40Speaker 4: about how we use our resources. So utilizing technologies such
- 28:46Speaker 4: as artificial intelligence in the space of you know, author asists,
- 28:52Speaker 4: or searching content more efficiently, automation of our voice of customers, trends,
- 28:59Speaker 4: and other rational efficiencies will ensure that, you know, we
- 29:03Speaker 4: are meeting the needs of our business as we are
- 29:06Speaker 4: taking on more work. And again, to finally wrap up
- 29:10Speaker 4: my thoughts in this space, you know, I know factam
- 29:13Speaker 4: is doing a lot of pilots and a lot of
- 29:15Speaker 4: work in the genai space that can be explored for
- 29:19Speaker 4: med info. So hope that helps, Evelyn. I'm going to
- 29:22Speaker 4: turn it over back to you.
- 29:25Speaker 11: That was great, And you know, I think the ideas
- 29:29Speaker 11: that you just came up with there, Lena, that you
- 29:33Speaker 11: were mentioning, I think, really do you know, encapsulate a
- 29:38Speaker 11: number of the different workstreams that factorm I currently is
- 29:41Speaker 11: participating in, and I think we'll really move forward and
- 29:46Speaker 11: elevate the practice of medical information.
- 29:50Speaker 1: As we start to close out this podcast, I just
- 29:53Speaker 1: wanted to review some of the key takeaways based on
- 29:56Speaker 1: our conversation to make sure we hit with some of
- 30:00Speaker 1: those objectives of this podcast were. So we've described the
- 30:04Speaker 1: value of medical information within the pharmaceutical company, really highlighting
- 30:11Speaker 1: how it is utilized throughout medical and even working with
- 30:18Speaker 1: some of our commercial partners. We've discussed the collaborative approach
- 30:24Speaker 1: behind creating and maintaining accurate drug information and being able
- 30:29Speaker 1: to disseminate that, utilizing that, and having people utilize that
- 30:34Speaker 1: information throughout the enterprise. And finally we identified what are
- 30:40Speaker 1: some of those future aspects for drug information sharing and
- 30:44Speaker 1: how fact am I make lay a role in that
- 30:47Speaker 1: future looking at that patient response hub. Talking also about
- 30:52Speaker 1: content and delivery, we know that you probably ten fifteen
- 30:56Speaker 1: years ago when somebody mentioned as scientific response dot document.
- 31:00Speaker 8: It was a ten to.
- 31:02Speaker 1: Twenty page letter that you've received, and now I think
- 31:05Speaker 1: most companies are trying to get it down to you
- 31:08Speaker 1: know that quick response might have that twenty page document
- 31:13Speaker 1: sitting somewhere in the background if you wanted to dig
- 31:16Speaker 1: into it, but really having that fast response that was
- 31:20Speaker 1: mentioned and making sure that that delivery is coming through
- 31:24Speaker 1: when and where are pharmacists and healthcare professionals need it.
- 31:29Speaker 1: We talked about misinformation both from a patient perspective, you
- 31:33Speaker 1: know what's out there, what people are hearing about, but
- 31:37Speaker 1: even from a healthcare perspective, understanding that you know, sometimes
- 31:42Speaker 1: the compendiums that we rely on might be missing some
- 31:47Speaker 1: of that information, or may not be as complete as
- 31:49Speaker 1: we wished, or may accurately actually have some inaccuracies. But
- 31:54Speaker 1: how can we as fact am I and as individual
- 31:59Speaker 1: medical information departments come together to really be able to
- 32:02Speaker 1: address that? And finally, I think you can address the
- 32:06Speaker 1: future without mentioning the generative AI side and how we
- 32:10Speaker 1: can how that will play a role in probably each
- 32:14Speaker 1: one of those other workstream that we were just talking about.
- 32:19Speaker 1: I just wanted to thank you guys, Stacey, Lena Vauce
- 32:22Speaker 1: for your input today. I think this was a great conversation.
- 32:27Speaker 1: This has been the fourth and final podcast in the series. Todd,
- 32:31Speaker 1: I'm sad to say, unless we come up with some
- 32:34Speaker 1: additional topics, it might be a minute before we get
- 32:37Speaker 1: to do this again. But thank you so much for
- 32:40Speaker 1: all of your support in this and I'll throw it
- 32:42Speaker 1: back over to.
- 32:43Speaker 5: You, Evely, and this has been an honor and a
- 32:50Speaker 5: privilege to partner with the Fact of My Team in
- 32:53Speaker 5: rolling out medical information to departments that are out there
- 32:57Speaker 5: that must continue to evolve to meet keate emer trends.
- 33:01Speaker 5: So much overwhelming amount of information we're getting into the
- 33:05Speaker 5: tarra bit level and the exponential growth of clinical data,
- 33:09Speaker 5: a growing care team is needed. Pharmacists are leading the way.
- 33:13Speaker 5: I'm of course biased because I just love pharmacists so much,
- 33:17Speaker 5: and how the collaboration between our physicians are, pharmacist are
- 33:21Speaker 5: nurses and all of the care teams in order to
- 33:24Speaker 5: assure that medical information is both accurate and accessible. Fact
- 33:29Speaker 5: OFMI is leading in this. We're so excited to promote
- 33:32Speaker 5: this four part series once again. If you haven't heard
- 33:35Speaker 5: all four parts, do not worry. We will have all
- 33:39Speaker 5: of these in one place for you to access through
- 33:42Speaker 5: the Pharmacy Podcast Network. We thank you for your work,
- 33:46Speaker 5: We thank you the Fact of My team. Congratulations on
- 33:49Speaker 5: your tenth year anniversary, and we can't wait to work
- 33:53Speaker 5: with FACTAMI again.